244 related articles for article (PubMed ID: 24167820)
1. Prognostic significance of HIF-1a, CA-IX, and OPN in T1-T2 laryngeal carcinoma treated with radiotherapy.
Wachters JE; Schrijvers ML; Slagter-Menkema L; Mastik M; de Bock GH; Langendijk JA; Kluin PM; Schuuring E; van der Laan BF; van der Wal JE
Laryngoscope; 2013 Sep; 123(9):2154-60. PubMed ID: 24167820
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of intrinsic hypoxia markers HIF1alpha and CA-IX predict for local recurrence in stage T1-T2 glottic laryngeal carcinoma treated with radiotherapy.
Schrijvers ML; van der Laan BF; de Bock GH; Pattje WJ; Mastik MF; Menkema L; Langendijk JA; Kluin PM; Schuuring E; van der Wal JE
Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):161-9. PubMed ID: 18722267
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylated FADD is not prognostic for local control in T1-T2 supraglottic laryngeal carcinoma treated with radiotherapy.
Wachters JE; Schrijvers ML; Slagter-Menkema L; Mastik M; Langendijk JA; de Bock GH; Roodenburg JL; van der Laan BFAM; van der Wal JE; Schuuring E
Laryngoscope; 2017 Sep; 127(9):E301-E307. PubMed ID: 28304089
[TBL] [Abstract][Full Text] [Related]
4. Distinct Biomarker Profiles and Clinical Characteristics in T1-T2 Glottic and Supraglottic Carcinomas.
Wachters JE; Kop E; Slagter-Menkema L; Mastik M; van der Wal JE; van der Vegt B; de Bock GH; van der Laan BFAM; Schuuring E
Laryngoscope; 2020 Dec; 130(12):2825-2832. PubMed ID: 32065407
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical detection of osteopontin in advanced head-and-neck cancer: prognostic role and correlation with oxygen electrode measurements, hypoxia-inducible-factor-1alpha-related markers, and hemoglobin levels.
Bache M; Reddemann R; Said HM; Holzhausen HJ; Taubert H; Becker A; Kuhnt T; Hänsgen G; Dunst J; Vordermark D
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1481-7. PubMed ID: 17056190
[TBL] [Abstract][Full Text] [Related]
6. HIF-1α and CA-IX as predictors of locoregional control for determining the optimal treatment modality for early-stage laryngeal carcinoma.
Kwon OJ; Park JJ; Ko GH; Seo JH; Jeong BK; Kang KM; Woo SH; Kim JP; Hwa JS; Carey TE
Head Neck; 2015 Apr; 37(4):505-10. PubMed ID: 24677746
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of hypoxia-associated markers in advanced larynx and hypopharynx squamous cell carcinoma.
Bernstein JM; Andrews TD; Slevin NJ; West CM; Homer JJ
Laryngoscope; 2015 Jan; 125(1):E8-15. PubMed ID: 25230150
[TBL] [Abstract][Full Text] [Related]
8. The relation between hypoxia and proliferation biomarkers with radiosensitivity in locally advanced laryngeal cancer.
van den Bovenkamp K; van der Vegt B; Halmos GB; Slagter-Menkema L; Langendijk JA; van Dijk BAC; Schuuring E; van der Laan BFAM
Eur Arch Otorhinolaryngol; 2023 Aug; 280(8):3801-3809. PubMed ID: 37029804
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical detection of HIF-1alpha and CAIX in advanced head-and-neck cancer. Prognostic role and correlation with tumor markers and tumor oxygenation parameters.
Kappler M; Taubert H; Holzhausen HJ; Reddemann R; Rot S; Becker A; Kuhnt T; Dellas K; Dunst J; Vordermark D; Hänsgen G; Bache M
Strahlenther Onkol; 2008 Aug; 184(8):393-9. PubMed ID: 18956515
[TBL] [Abstract][Full Text] [Related]
10. Lack of prognostic effect of carbonic anhydrase-9, hypoxia inducible factor-1α and bcl-2 in 286 patients with early squamous cell carcinoma of the glottic larynx treated with radiotherapy.
Douglas CM; Bernstein JM; Ormston VE; Hall RC; Merve A; Swindell R; Valentine HR; Slevin NJ; West CM; Homer JJ
Clin Oncol (R Coll Radiol); 2013 Jan; 25(1):59-65. PubMed ID: 22841149
[TBL] [Abstract][Full Text] [Related]
11. Retrospective analysis of 659 laryngeal squamous cell carcinoma patients treated with open laryngeal function-preserving operations.
Tang D; Tao L; Zhou L; Zhang M; Wu H; Li X; Chen X; Li C; Xie M; Cheng L
Acta Otolaryngol; 2018 Nov; 138(11):1043-1050. PubMed ID: 30776268
[TBL] [Abstract][Full Text] [Related]
12. Impact of stage, management and recurrence on survival rates in laryngeal cancer.
Brandstorp-Boesen J; Sørum Falk R; Boysen M; Brøndbo K
PLoS One; 2017; 12(7):e0179371. PubMed ID: 28708883
[TBL] [Abstract][Full Text] [Related]
13. Expression of EpCAM and prognosis in early-stage glottic cancer treated by radiotherapy.
Murakami N; Mori T; Yoshimoto S; Ito Y; Kobayashi K; Ken H; Kitaguchi M; Sekii S; Takahashi K; Yoshio K; Inaba K; Morota M; Sumi M; Itami J
Laryngoscope; 2014 Nov; 124(11):E431-6. PubMed ID: 25043563
[TBL] [Abstract][Full Text] [Related]
14. HIF-1alpha and CA IX staining in invasive breast carcinomas: prognosis and treatment outcome.
Trastour C; Benizri E; Ettore F; Ramaioli A; Chamorey E; Pouysségur J; Berra E
Int J Cancer; 2007 Apr; 120(7):1451-8. PubMed ID: 17245699
[TBL] [Abstract][Full Text] [Related]
15. Postoperative radiotherapy for laryngeal carcinoma: the prognostic role of subcellular Maspin expression.
Lionello M; Blandamura S; Staffieri C; Tealdo G; Giacomelli L; Marchese Ragona R; de Filippis C; Staffieri A; Marioni G
Am J Otolaryngol; 2015; 36(2):184-9. PubMed ID: 25459315
[TBL] [Abstract][Full Text] [Related]
16. [Expression and clinical pathological implications of carbonic anhydrase 9 and P glycoprotein in laryngeal squamous cell carcinoma].
Chen X; Wang F; Xie F; Dong P; Ying X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jan; 30(1):42-4. PubMed ID: 27197454
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of carbonic anhydrase IX and Ki-67 expression in squamous cell carcinoma of the tongue.
Kim SJ; Shin HJ; Jung KY; Baek SK; Shin BK; Choi J; Kim BS; Shin SW; Kim YH; Kim JS; Oosterwijk E
Jpn J Clin Oncol; 2007 Nov; 37(11):812-9. PubMed ID: 18057013
[TBL] [Abstract][Full Text] [Related]
18. Positive BCL2L12 expression predicts favorable prognosis in patients with laryngeal squamous cell carcinoma.
Giotakis AI; Lazaris AC; Kataki A; Kontos CK; Giotakis EI
Cancer Biomark; 2019; 25(2):141-149. PubMed ID: 31104007
[TBL] [Abstract][Full Text] [Related]
19. Carbonic anhydrase enzymes II, VII, IX and XII in colorectal carcinomas.
Viikilä P; Kivelä AJ; Mustonen H; Koskensalo S; Waheed A; Sly WS; Pastorek J; Pastorekova S; Parkkila S; Haglund C
World J Gastroenterol; 2016 Sep; 22(36):8168-77. PubMed ID: 27688658
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of hypoxia markers in T2-staged oral tongue cancer.
Roh JL; Cho KJ; Kwon GY; Ryu CH; Chang HW; Choi SH; Nam SY; Kim SY
Oral Oncol; 2009 Jan; 45(1):63-8. PubMed ID: 18620902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]